Deadlock Claims Data Leak at Italian Pharma Company idi pharma

Summary

Ransomware group Deadlock claims to have leaked data from Italian pharmaceutical company idi pharma, including proprietary formulations and dosage technology. The claim has not been independently confirmed.

Key points

Victim: idi pharma, an Italian company in the pharmaceutical and medical-device sector.
The post attributes the ransomware data-leak claim to Deadlock.
The claimed exposed data includes patented formulations and dosage technology.
The listing says the claim was published on October 9, 2026, and notes it is unconfirmed.

Article Details

Victim: idi pharma
Claim Date: 2026-10-09
Encryption Status: Unknown
Exfiltration Status: Unknown
Exfiltrated Data: The article says the victim's data was leaked and claims proprietary patented formulations and unique dosage technology were exposed; the information is attributed to Deadlock and is unconfirmed.
Ransom Demand: Unknown
Leak Status: The article reports that the data was leaked, based on an unconfirmed public claim attributed to Deadlock.

Threat Actors

DeadlockRansomware actor to which the data-leak claim is attributed; the article says the claim is unconfirmed.

Countries

SpainThe attack impacted the company’s stolen information and exposure of proprietary patented formulations and unique dosage technology, resulting in data compromise for #Spain

Industries

HealthcareSector: Healthcare pharmaceuticalidi pharma (ES) an Italian pharmaceutical company specializing in innovative nutraceuticals and medical devices reported a ransomware data leak attributed to Threat Actor Deadlock.